Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -435,438.00 |
| Dec 31, 2023 | 845,676.00 |
| Sep 30, 2023 | 484,703.00 |
| Jun 30, 2023 | 562,953.00 |
| Mar 31, 2023 | -72,324.00 |
| Dec 31, 2022 | -885,341.00 |
| Sep 30, 2022 | -442,667.00 |
| Jun 30, 2022 | -329,140.00 |
| Mar 31, 2022 | -2,903.00 |
| Dec 31, 2021 | -50,946.00 |
| Sep 30, 2021 | 4,409.00 |
| Jun 30, 2021 | -228,226.00 |
| Mar 31, 2021 | -1,296.00 |
| Dec 31, 2020 | 37,536.00 |
| Sep 30, 2020 | -51,037.00 |
| Jun 30, 2020 | 17,244.00 |
| Mar 31, 2020 | 8,976.00 |
| Dec 31, 2019 | 194,254.00 |
| Sep 30, 2019 | 5,660.00 |
| Jun 30, 2019 | -21,878.00 |